NEWS

NEWS TYPE
RELEASE YEAR

EVENT

【1/7 Seminar】WPI-Bio2Q Open Seminar: Masahiro Kanai, PhD

December 18, 2025

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows.

This is an event for faculty, students, and staff of Keio University.

Date & Time 17:00 -18:00 January 7, 2026
Venue JKiC 1F, Shinanomachi Campus, Keio University
Title Population-scale multiome immune cell atlas reveals complex disease drivers
Speaker Masahiro Kanai, PhD,
Instructor in Medicine, Center for Computational and Integrative Biology
Massachusetts General Hospital
Broad Institute of MIT and Harvard
USA
Language English
Poster PDF
Onsite Pre-registration not required

Most genetic variants associated with complex diseases lie in non-coding regions, yet mechanistic insights have been limited by the lack of an empirical framework for characterizing the molecular consequences of regulatory variation. Single-cell profiling of molecular quantitative trait loci (QTL) can connect variants to gene regulation, but prior studies lacked the sample size to detect variants at disease-relevant genes and the simultaneous measurements across regulatory layers needed to trace complete mechanisms from chromatin state to gene expression. Here we show that population-scale simultaneous profiling of chromatin accessibility and gene expression across immune cell types reveals multi-layered regulatory pathways connecting genetic variants to disease. We generated paired single-nucleus ATAC-seq and RNA-seq profiles from 10 million peripheral blood mononuclear cells across 1,108 Finnish individuals, identifying 51,083 cis-eQTLs for 20,829 genes, 338,100 cis-caQTLs for 210,584 peaks, 119,094 fine-mapped variants, and 496,488 enhancer–gene links. Systematic classification of regulatory mechanisms revealed that variants with complete chromatin-to-expression cascades show twice the disease colocalization of chromatin-only effects, establishing a hierarchy where mechanistic cascade predicts disease relevance. Analysis of evolutionarily constrained genes revealed multi-layered regulatory buffering where chromatin accessibility changes occur with normal effect sizes, but transmission to gene expression is attenuated through systematically weaker enhancer–gene links, reconciling why disease variants preferentially target these genes despite apparent eQTL depletion. We incorporated base editing to experimentally validate causal variants and mechanisms at Finnish-enriched disease loci such as TNRC18. This resource provides testable mechanistic hypotheses for over half of immune disease associations.

https://doi.org/10.1101/2025.11.25.25340489

More Bio2Q News

RESEARCH
2026.01.15

[Publication]M cell–dependent commensal uptake confers encephalitogenic phenotyp...

Co-authored by researchers from Bio2Q and Keio University, and published in Proceedings of the National Academy of Sciences (PNAS), this stu...

EVENT
2026.01.08

【Seminar Report】WPI-Bio2Q Open Seminar

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held a seminar as follows. 17:00 -18:00 January 7, 2026 V...

RESEARCH
2026.01.08

[Publication]Niche-preserving transplantation promotes functional engraftment of...

Co-authored by Bio2Q and Keio University researchers, this study demonstrates a niche-preserving transplantation strategy that enables highl...

ANNOUNCEMENT
2025.12.29

WPI-Bio2Q Newsletter "Bio2Q Connect" Vol. 2, Issue 12 Released

WPI-Bio2Q has released the latest issue of our newsletter, "Bio2Q Connect" (Vol. 2, Issue 12). This issue highlights the selection of six...

ANNOUNCEMENT
2025.12.24

【Seminar】 WPI-Bio2Q Open Seminar: Tomoe Ishikawa, Ph.D.(for Keio Members)

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This event is only for faculty...